Abstract
Highlights The study demonstrates that in patients with uncomplicated STEMI and intermediate stenoses of non-infarct-related arteries, performing staged complete revascularization only with a hemodynamically significant fractional flow reserve (FFR) value ≤ 0.80 at 30–45 days after primary intervention is associated with no cases of cardiovascular death and recurrent myocardial infarction over a median follow-up of 21 months. The uniqueness of the approach lies in the selection of hemodynamically significant stenoses, which avoided excessive stenting in 40% of patients without worsening prognosis. Thus, the work makes an important contribution to the rationale for FFR-guided staged complete revascularization in STEMI patients with multivessel coronary artery disease. Aim. To evaluate the incidence of major adverse cardiovascular events in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease after staged complete revascularization of non-infarct-related arteries (non-IRAs) guided by fractional flow reserve (FFR). Methods. This single-center prospective study included 52 patients with STEMI and intermediate non-IRA stenoses (50–85%). All patients underwent primary percutaneous coronary intervention of the infarct-related artery. At 30–45 days, FFR assessment in non-IRAs was performed; revascularization was performed when FFR ≤ 0.80. Median follow-up was 21 months. The primary endpoint was cardiovascular death and recurrent myocardial infarction. Results. Hemodynamically significant stenoses were identified in 31 patients (59.6%), who underwent stenting; 21 patients (40.4%) received only medical therapy. During the follow-up period, no cases of cardiovascular death or recurrent myocardial infarction were recorded (0%; 95% CI 0.0–5.6%). Repeat revascularization was performed in 4 patients (7.7%), and 2 cases of non-cardiovascular death (3.8%) were recorded. No cases of contrast-induced nephropathy, clinically significant bleeding, or stroke were observed. Conclusion. In patients with uncomplicated STEMI and intermediate non-IRA stenoses, an FFR-guided staged complete revascularization strategy performed at 30–45 days after primary intervention was associated with a low incidence of cardiovascular events; no cases of cardiovascular death or recurrent myocardial infarction were recorded in this cohort. This approach avoids excessive stenting but requires confirmation in larger studies.

This publication has 14 references indexed in Scilit: